Dr. Horng is board-certified in critical care medicine, internal medicine, and pulmonary disease, and he specializes in the evaluation and diagnosis of pulmonary nodules and masses. He has co-authored clinical research papers on predicting tumor response to therapy after oncogene inactivation; progressive dyspnea after CABG; tumorigenesis in lung adenocarcinomas; and multidrug resistance in cancer cells. Past honors for Dr. Horng include a Teacher of the Year Award for CPMC’s Internal Medicine Residency Program and an American Thoracic Society Fellows Career Development Award. He was Resident of the Year at the University of California, Los Angeles/Greater Los Angeles VA Medical Center Internal Medicine Training Program.
Sutter Health Research Enterprise
2351 Clay Street Suite 501
San Francisco, CA, 94115
(415) 923-3421
horngg@sutterhealth.org
Primary Research Interests
Related Clinical Trials
iLuekPulm
Study of Sargramostim in Patients With COVID-19 (iLeukPulm)
Investigators: Ryan Dougherty M.D., George Horng M.D.
Status: Active, Not Recruiting
SEER Study
SEER-Lung: A Prospective Blood Sample Collection Study to Develop and Validate a Panel of Proteinbased Biomarkers in Patients with Pulmonary Nodules
Investigators: Tze-Ming Chen M.D., FCCP, Jey Chung MD, George Horng M.D., Heba Ismail M.D., Chad T Tao M.D.
Status: Active, Recruiting